首页> 外文会议>Bioengineering and Translational Medicine Conference >Cartilage Penetrating Nanocarriers to Provide Sustained Delivery of Disease Modifying Drugs In Post-Traumatic Osteoarthritis
【24h】

Cartilage Penetrating Nanocarriers to Provide Sustained Delivery of Disease Modifying Drugs In Post-Traumatic Osteoarthritis

机译:软骨穿透纳米载波,可在创伤后骨关节炎中提供疾病改性药物的持续交付

获取原文

摘要

Osteoarthritis is a debilitating disease of the joint.There are a variety of causes of osteoarthritis a however,one particular etiology,post-traumatic osteoarthritis(PTOA),is of particular clinical interest because it has a biologically and temporally well-defined onset a a traumatic joint injury.There is potential for immediate post-injury intervention with a drug to mitigate the progression of the disease.However,no such disease modifying osteoarthritis drug currently exists.
机译:骨关节炎是联合的衰弱疾病。然而,骨关节炎的各种原因是,一种特定的病因,创伤后骨关节炎(PTOA)是特别的临床兴趣,因为它具有生物学和时间明确的发作AA创伤性联合伤害。有可能立即对药物进行损伤后干预,以减轻疾病的进展。然而,没有这种疾病,这种疾病目前存在治疗骨关节炎药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号